Atea Pharmaceuticals, Inc.
AVIR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $65 | $144 | $647 | $764 |
| Short-Term Investments | $390 | $434 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $8 | $12 | $14 | $8 |
| Total Curr. Assets | $462 | $590 | $661 | $772 |
| Property Plant & Equip (Net) | $2 | $3 | $4 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $1 | $1 | $0 |
| Total NC Assets | $2 | $5 | $6 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $465 | $595 | $667 | $773 |
| Liabilities | – | – | – | – |
| Payables | $4 | $4 | $3 | $5 |
| Short-Term Debt | $1 | $1 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $13 | $27 | $15 | $52 |
| Total Curr. Liab. | $19 | $32 | $18 | $57 |
| LT Debt | $1 | $2 | $2 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $6 | $6 | $5 | $6 |
| Total NC Liab. | $7 | $7 | $8 | $6 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $2 | $3 | $0 |
| Total Liabilities | $26 | $40 | $26 | $63 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$364 | -$196 | -$60 | $56 |
| AOCI | $0 | $0 | -$1 | -$0 |
| Other Equity | $803 | $751 | $701 | $654 |
| Total Equity | $439 | $555 | $641 | $710 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $465 | $595 | $667 | $773 |
| Net Debt | -$63 | -$141 | -$644 | -$764 |